In 1999, she returned to Glasgow Royal Infirmary and in 2004 became Professor of Experimental Haematology, and Director of the Leukaemia Research Centre.[3] In 2005, she first presented work showing that a combination of imatinib or dasatinib with a farnesyl transferase inhibitor was better at eradicating CML stem cells, which was published in 2007.[6]